Atlas Trials

Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC

Clinical trial NCT07523789 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07523789
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
TNBC, Triple Negative Breast Cancer
Start date
2026-05-01
Primary completion
2027-02-01
Enrollment
201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.